首页>
外国专利>
COMBINATION COMPRISING RADIUM-223 FOR THE TREATMENT OF CANCER
COMBINATION COMPRISING RADIUM-223 FOR THE TREATMENT OF CANCER
展开▼
机译:镭223联合治疗癌症
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to combinations comprising compounds A and B, compound A being a 17α-hydroxylase/C17,20-lyase (CYP17) inhibitor, and compound B being a pharmaceutically acceptable salt of the alkaline-earth radionuclide radium-223 and their use for the treatment or prophylaxis of a disease, particularly for the treatment of cancer.
展开▼
机译:本发明涉及包含化合物A和B,化合物A为17α-羟化酶/ C 17,20 Sub>-裂合酶(CYP17)抑制剂和化合物B为碱式药学上可接受的盐的组合。放射性核素镭223,及其在疾病的治疗或预防中的用途,特别是在癌症的治疗中。
展开▼